Law360, Los Angeles (September 13, 2019, 1:12 PM EDT) -- A California federal jury on Friday cleared Quest Diagnostics of allegations it stole Cedars-Sinai Medical Center's trade secrets in a bid to develop a competing diagnostic blood test.
After deliberating for more than a day, the eight-member jury rejected the research hospital's accusations that Quest misappropriated its trade secrets to create a rival test for irritable bowel syndrome, or IBS, after Quest's bid to license the technology fell through.
The jury also found that Quest did not use confidential information in breach of its nondisclosure agreement with Cedars-Sinai.
Counsel for Quest told Law360 on Friday they were pleased with the jury's verdict...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!